As an ophthalmologist with specialization in retinal diseases, Grover sees patients with macular degeneration, diabetic retinopathy and inherited retinal diseases.
“We’ve seen remarkable preservation of vision with the treatment options available today for a number of conditions,” said Grover. “AMD is treated with intravitreal injections of medications given every four to six weeks with continuous monitoring by eye exams and tests in between the injections.”
During an intravitreal injection, medications are injected into the “jelly-like” vitreous that fills the eye so the medication is readily available to the retina. According to the American Society of Retina Specialists, they became more common after 2006 when the types of available medications expanded to treat more conditions. The medications act to reduce fluid leakage associated with disorders including AMD, diabetic retinopathy and vascular occlusions.
“I call them miracle drugs because if the patient can be seen and given injections within a short period after diagnosis of wet AMD, the medications will either stabilize or improve the vision,” said Grover.
Typically, patients feel pressure with little or no pain during the injection. It is a relatively less invasive treatment and performed as an outpatient procedure with good tolerance by patients, according to Grover.